Oncology clinical trials in Asia-pacific region

The APAC region has had a remarkable increase in oncology clinical trial activity, and it is currently leading the world in the overall number of ongoing oncology clinical studies. The Asia-Pacific region has emerged as an epicenter of clinical trial activity, accounting for over half of total global clinical trials. With these growth tendencies projected […]

Read More →
Nutraceutical clinical trials in ASIA Pacific region

Nutraceutical clinical trials are steadily increasing in the Asia-Pacific region. The nutraceutical market in the Asia-Pacific is experiencing tremendous growth and is expected to expand further. The Asia-Pacific region, encompassing countries like Australia, India, Japan, and China, offers significant opportunities for the nutraceutical market due to its large population, rising disposable income, and growing focus […]

Read More →
Cosmetics registration process in Thailand

Cosmetic product registration in Thailand has become faster and more environmentally friendly since November 1, 2010, when the Thai FDA adopted a new online cosmetic product registration system. Thailand’s cosmetics business is expanding, offering a wide range of beauty and personal care products. Thailand established a comprehensive regulatory framework to ensure consumer safety while maintaining […]

Read More →
Why ASIA-PACIFIC Leads The World In Clinical Trials

The Asia-Pacific region, with over half of the global population, is becoming a growing popular spot for conducting clinical trials by offering lower trial costs, access to large patient pools, and a friendly regulatory environment. These distinguishing traits are increasing interest in medical device, pharmaceutical, and healthcare companies to shift their clinical trial locations to […]

Read More →
New drug registration process in south korea

As South Korea emerges as a focal point for new drugs, understanding the drug registration and approval process becomes crucial for those intending to market their products in the country. With a population that values advancements in healthcare, there’s a constant search for effective treatments and solutions in South Korea. The demand extends across numerous medical […]

Read More →

Comprehending the function of clinical trial investigators and the accessibility of appropriate trial sites is essential, as it signifies the commencement of the market availability of your healthcare product following a successful clinical trial. The Asia-Pacific region is gaining prominence in the world of healthcare products. The healthcare market in the Asia-Pacific region is expected […]

Read More →
New Drug Registration and Approval Process In Thailand

The new drug registration process in Thailand is complex, but with careful planning, expertise, and assistance from regulatory consultants or legal professionals, it can be navigated more easily and efficiently. The market for new drugs in Thailand is growing steadily, with an increasing demand for innovative pharmaceutical products. The market for new drugs accounts for […]

Read More →
Healthcare business expansion in Asia-pacific region

Asia-Pacific is a top destination for growing healthcare companies, with the APAC Healthcare Analytics Market size projected to increase by USD 20.84 billion at a CAGR of 27.94% between 2023 and 2028. The region offers opportunities for several healthcare products, such as pharmaceuticals, medical devices, cosmetics, and nutraceuticals. As APAC continues to experience economic development […]

Read More →
Singapore for Your Healthcare Products Market

The Singaporean healthcare and pharmaceutical market presents a lucrative opportunity for businesses aiming to expand their reach. Singapore presents a compelling opportunity for producers and distributors of healthcare products due to its sophisticated infrastructure, highly regulated industry, and dense population. Situated at the crossroads of Asia, Singapore boasts a dynamic economy, world-class infrastructure, and a […]

Read More →
Import of IMPs & ancillaries for clinical trials

Importing Ancillaries and IMPs for clinical trials in the Asia-Pacific region presents numerous challenges. Navigating diverse regulatory landscapes, and logistical complexities, ensuring quality control, and managing timeliness and costs are critical hurdles. Effective risk mitigation strategies are essential for overcoming potential disruptions. Overall, addressing these challenges is vital for the successful execution of clinical trials […]

Read More →